Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.
about
Alteration of SHP-1/p-STAT3 Signaling: A Potential Target for Anticancer Therapy.The oncogenic potential of human cytomegalovirus and breast cancer.SHP-1 is a target of regorafenib in colorectal cancer.SC-2001 overcomes STAT3-mediated sorafenib resistance through RFX-1/SHP-1 activation in hepatocellular carcinomaRepurposing FDA-approved drugs as therapeutics to treat Rift Valley fever virus infection.Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review).Protein tyrosine phosphatase SHP-1 sensitizes EGFR/HER-2 positive breast cancer cells to trastuzumab through modulating phosphorylation of EGFR and HER-2.Pharmacological Targeting SHP-1-STAT3 Signaling Is a Promising Therapeutic Approach for the Treatment of Colorectal Cancer.Promotion of Cancer Stem-Like Cell Properties in Hepatitis C Virus-Infected HepatocytesOlmesartan potentiates the anti-angiogenic effect of sorafenib in mice bearing Ehrlich's ascites carcinoma: role of angiotensin (1-7)Regorafenib (Stivarga) pharmacologically targets epithelial-mesenchymal transition in colorectal cancer.SHP-1 is a negative regulator of epithelial-mesenchymal transition in hepatocellular carcinoma.Obatoclax analog SC-2001 inhibits STAT3 phosphorylation through enhancing SHP-1 expression and induces apoptosis in human breast cancer cells.CD24 mediates gastric carcinogenesis and promotes gastric cancer progression via STAT3 activation.Sorafenib analogue SC-60 induces apoptosis through the SHP-1/STAT3 pathway and enhances docetaxel cytotoxicity in triple-negative breast cancer cells.The tyrosine kinase inhibitor nintedanib activates SHP-1 and induces apoptosis in triple-negative breast cancer cells.Sorafenib induces cathepsin B-mediated apoptosis of bladder cancer cells by regulating the Akt/PTEN pathway. The Akt inhibitor, perifosine, enhances the sorafenib-induced cytotoxicity against bladder cancer cells.Hepatic stellate cell coculture enables sorafenib resistance in Huh7 cells through HGF/c-Met/Akt and Jak2/Stat3 pathwaysErratum to: Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.Targeting SHP-1-STAT3 signaling: A promising therapeutic approach for the treatment of cholangiocarcinoma.Epigallocatechin-3-gallate induces apoptosis in acute promyelocytic leukemia cells via a SHP-1-p38α MAPK-Bax cascade.WMJ-8-B, a novel hydroxamate derivative, induces MDA-MB-231 breast cancer cell death via the SHP-1-STAT3-survivin cascade.Synthesis and cytotoxic evaluation of some novel quinoxalinedione diarylamide sorafenib analogues.Synergistic antitumor effects of tanshinone IIA and sorafenib or its derivative SC-1 in hepatocellular carcinoma cells.SET Overexpression is Associated with Worse Recurrence-Free Survival in Patients with Primary Breast Cancer Receiving Adjuvant Tamoxifen Treatment
P2860
Q33838824-BB90A128-ACA7-4255-A1D9-326F656435BAQ34081724-E830777F-45BA-49D2-8984-23CDD7E4C8E3Q34227671-19EB1055-A104-41B4-B6DC-8EBD1CABE3F1Q34347235-5CE9F040-ECE9-40A5-9D2C-6EB01DDD52B4Q35718193-0B6418EF-341A-4780-BEB9-D71EA016CFBEQ35934485-F7EA0634-9029-4E94-8A14-FC7D3742A4ECQ36078326-7896A037-0F59-4770-ACC8-261DE5BE8336Q36177646-38684B1D-2A97-40E2-B98D-8E3D416456C6Q36281852-DDE4F9D7-0FE7-4B98-8435-DB12819E2DC0Q37505197-654F4580-C6AA-401A-BB93-A51CABC76B8BQ37665603-698CAA02-3674-4A7B-85C3-7462E9CF2E5FQ38916619-CB3FFEC8-58A3-45CE-8F25-D864D0B2E199Q38987827-2908A4E9-C546-49D9-8BCC-E0F984FE692CQ39044616-1462CA29-2056-4FDE-9E46-4D228CD65245Q41127816-D6A90026-0EF6-4412-B5AC-5226CF3AD9C9Q41583233-65C3B0AE-EB81-4F43-90FF-4E756A783EC1Q41770394-B80959B3-7ED4-4906-B68C-8F575DD68FC6Q42181154-B95ABE49-E9BB-4D2C-9E49-D91845529C27Q42331647-52C4F9BE-2F56-44E6-AE98-152422C44F9AQ42371502-9BC5E748-E1AA-41A5-A7B7-B97A1103CD92Q46094753-54973C62-6926-4783-9587-68C8DEA56D2CQ48227330-DA6E8ED2-17B3-438C-8300-9C0F02B4F041Q51731233-0E583A61-E36E-48A6-A6D9-B646106D09A5Q52720194-677515D1-8B9E-4F57-A905-498483B9797CQ58697376-5623DB67-AE70-43FE-8FFB-CB3523794DAF
P2860
Novel sorafenib analogues induce apoptosis through SHP-1 dependent STAT3 inactivation in human breast cancer cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Novel sorafenib analogues indu ...... in human breast cancer cells.
@en
Novel sorafenib analogues indu ...... in human breast cancer cells.
@nl
type
label
Novel sorafenib analogues indu ...... in human breast cancer cells.
@en
Novel sorafenib analogues indu ...... in human breast cancer cells.
@nl
prefLabel
Novel sorafenib analogues indu ...... in human breast cancer cells.
@en
Novel sorafenib analogues indu ...... in human breast cancer cells.
@nl
P2093
P2860
P356
P1476
Novel sorafenib analogues indu ...... in human breast cancer cells.
@en
P2093
Chun-Yu Liu
Chung-Wai Shiau
Jung-Chen Su
Kuen-Feng Chen
Kung-Chi Chang
Ling-Ming Tseng
Pei-Yi Chu
Wei-Tien Tai
P2860
P2888
P356
10.1186/BCR3457
P577
2013-01-01T00:00:00Z
P5875
P6179
1017005021